NCT02206841View on ClinicalTrials.gov

Establishment of NAFLD Cohort and Development of Fibrosis Markers

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions
Fibrosis of Liver
Interventions
PROCEDURE

Liver biopsy

Percutaneously liver biopsy will be performed for evaluate steatosis and fibrosis.

DEVICE

ARFI

Acoustic radiation force impulse (ARFI) imaging will be performed for evaluate fibrosis of liver.

DEVICE

SWE

Supersonic shear wave elastography (SWE) will be performed for evaluate fibrosis of liver.

DEVICE

Transient elastography

Transient elastography will be performed for evaluate fibrosis of liver.

Trial Locations (1)

156-707

RECRUITING

Seoul Metropolitan Government Seoul National University, Seoul

All Listed Sponsors
lead

Seoul National University Boramae Hospital

OTHER